Theriva Biologics, Inc. Increase (Decrease) in Deferred Compensation
Theriva Biologics, Inc. (TOVX) reported Increase (Decrease) in Deferred Compensation of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCompensation · last filed 2020-02-20
- Theriva Biologics, Inc. increase (decrease) in deferred compensation for the quarter ending 2019-12-31 was $0.00.
- Theriva Biologics, Inc. increase (decrease) in deferred compensation for the quarter ending 2019-09-30 was $0.00.
- Theriva Biologics, Inc. increase (decrease) in deferred compensation for the quarter ending 2019-06-30 was $0.00.
- Theriva Biologics, Inc. increase (decrease) in deferred compensation for the quarter ending 2019-03-31 was $0.00.
- Theriva Biologics, Inc. increase (decrease) in deferred compensation for fiscal 2019 was $0.00.
- Theriva Biologics, Inc. increase (decrease) in deferred compensation for fiscal 2018 was -$90.00K.
- Theriva Biologics, Inc. increase (decrease) in deferred compensation for fiscal 2017 was -$3.00K, a 101.45% decline from fiscal 2016.
- Theriva Biologics, Inc. increase (decrease) in deferred compensation for fiscal 2016 was $207.00K, a 28.13% decline from fiscal 2015.
| Period end | Increase (Decrease) in Deferred Compensation 3 month | Increase (Decrease) in Deferred Compensation 6 month | Increase (Decrease) in Deferred Compensation 9 month | Increase (Decrease) in Deferred Compensation 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $0.00 derived: sum of 2 quarters · filed 2020-02-20 | $0.00 derived: sum of 3 quarters · filed 2020-02-20 | $0.00 10-K · filed 2020-02-20 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | -$24.00K derived: sum of 4 quarters · filed 2020-02-20 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | -$24.00K derived: sum of 3 quarters · filed 2020-02-20 | -$46.00K derived: sum of 4 quarters · filed 2020-02-20 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 | -$24.00K derived: sum of 2 quarters · filed 2020-02-20 | -$46.00K derived: sum of 3 quarters · filed 2020-02-20 | -$68.00K derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | -$46.00K derived: sum of 2 quarters · filed 2020-02-20 | -$68.00K derived: sum of 3 quarters · filed 2020-02-20 | -$90.00K 10-K · filed 2020-02-20 |
| 2018-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$44.00K derived: sum of 2 quarters · filed 2019-11-04 | -$66.00K 10-Q · filed 2019-11-04 | -$88.00K derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$44.00K 10-Q · filed 2019-08-08 | -$66.00K derived: sum of 3 quarters · filed 2019-08-08 | -$76.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$22.00K 10-Q · filed 2019-05-08 | -$44.00K derived: sum of 2 quarters · filed 2019-05-08 | -$54.00K derived: sum of 3 quarters · filed 2019-05-08 | -$40.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$32.00K derived: sum of 2 quarters · filed 2019-02-27 | -$18.00K derived: sum of 3 quarters · filed 2019-02-27 | -$3.00K 10-K · filed 2019-02-27 |
| 2017-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $4.00K derived: sum of 2 quarters · filed 2018-11-08 | $19.00K 10-Q · filed 2018-11-08 | $249.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $29.00K 10-Q · filed 2018-08-08 | $259.00K derived: sum of 3 quarters · filed 2018-08-08 | $246.00K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $15.00K 10-Q · filed 2018-05-08 | $245.00K derived: sum of 2 quarters · filed 2018-05-08 | $232.00K derived: sum of 3 quarters · filed 2018-05-08 | $221.00K derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $217.00K derived: sum of 2 quarters · filed 2018-02-22 | $206.00K derived: sum of 3 quarters · filed 2018-02-22 | $207.00K 10-K · filed 2018-02-22 |
| 2016-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$24.00K derived: sum of 2 quarters · filed 2017-11-01 | -$23.00K 10-Q · filed 2017-11-01 | $12.00K derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$10.00K 10-Q · filed 2017-08-03 | $25.00K derived: sum of 3 quarters · filed 2018-02-22 | $278.00K derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $1.00K 10-Q · filed 2017-05-04 | $36.00K derived: sum of 2 quarters · filed 2018-02-22 | $289.00K derived: sum of 3 quarters · filed 2018-02-22 | $289.00K derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $288.00K derived: sum of 2 quarters · filed 2018-02-22 | $288.00K derived: sum of 3 quarters · filed 2018-02-22 | $288.00K 10-K · filed 2018-02-22 |
| 2015-09-30 | $253.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $253.00K derived: sum of 2 quarters · filed 2016-11-01 | $253.00K 10-Q · filed 2016-11-01 | $253.00K derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $0.00 10-Q · filed 2016-08-03 | $0.00 derived: sum of 3 quarters · filed 2017-03-02 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $0.00 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-05 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |